Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)
First Topical Therapy Developed to Treat the Wounds and Lesions on the Entire Skin Surface Across All EB Subtypes Funding to be Used for Completion of All Activities to Support Planned NDA Submission in the Second Half of 2025, Along with Plans for...
ROHM Develops New High-power-density SiC Power Modules
- Compact, High-heat-dissipation Design Sets New Standard for OBC - KYOTO, Japan, April 24, 2025 /PRNewswire/ -- ROHM Co., Ltd. has developed new 4-in-1 and 6-in-1 SiC molded modules in the HSDIP20 package for power-factor-correction (PFC) circuits...
Heng Ren Partners Calls on Sinovac to Disclose the Record and Payment Dates of the Special Dividend and Distribute an Additional Dividend of $41 per Share
BOSTON, April 11, 2025 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) shareholder Heng Ren Partners, LLC sent a letter on April 8, 2025, to Sinovac's Board calling on the Board to disclose the record and payment dates of the special cash...
Enfinity Global Statement on CEO Carlos Domenech
MIAMI, April 2, 2025 /PRNewswire/ -- As stated in the press release issued by TerraForm Power Parent, LLC on April 1, 2025, via GlobeNewswire: "On January 20, 2025, a lawsuit filed in the United States District Court for the District of Maryland...
Heng Ren Partners Demands Sinovac Distribute $8.9 Billion in Cash to its Shareholders and Cause Reinstatement of Trading
BOSTON, March 20, 2025 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac") shareholder Heng Ren Partners, LLC funds ("Heng Ren") today sent an open letter to Sinovac's shareholders outlining the significant and decisive action that...
KPM Analytics Secures Legal Victory in Trade Secret Misappropriation Case
Court awards $10M to KPM Analytics in Trade Secret Theft and Tortious Interference Case, Reinforcing Commitment to Innovation and Fair Competition. WESTBOROUGH, Mass., March 3, 2025 /PRNewswire/ -- KPM Analytics, a global leader in analytical...
Hedgehog Risk Secures Investment From SIG Insurance Holdings, LLC
Member of the Susquehanna International Group of Companies, a global quantitative trading and investment firm, takes a significant stake in one of the leading providers of specialist sports and prize insurance LONDON, Jan. 28, 2025 /PRNewswire/ --...
DASI, LLC appoints new President as it continues to drive growth and strengthen leadership in the Aviation Aftermarket
Industry veteran Mike Heaton takes the helm to accelerate innovation and further enhance DASI, LLC's market position MIAMI, Jan. 13, 2025 /PRNewswire/ -- DASI, LLC, a premier provider of aircraft inventory solutions, is pleased to announce the...
![Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma](http://prnewswire.vietreader.com/thumb/190x300/2025-01/norgine-submits-marketing-authorisation-application-to-the-european-medicines-agency-for-eflornithine-difluoromethylornithine-dfmo-in-high-risk-neuroblastoma-1.jpg)
Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma
Back to media releases Next media release LONDON, Jan. 7, 2025 /PRNewswire/ -- Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma...
Designs For Health Inc. Held Liable For Infringement of Kaneka's Ubiquinol Patent
TOKYO, Dec. 25, 2024 /PRNewswire/ -- Kaneka has successfully defended its patent for stabilizing Ubiquinol. On December 20, 2024, Kaneka Corporation won its lawsuit against Designs for Health, Inc. and American River Nutrition, LLC for infringement...